Company hopes generic versions of MS drug will be delayed by clinical trials.
By SHIRI HABIB-VALDHORN
Published: DECEMBER 6, 2012 00:01
Teva 311
(photo credit: REUTERS/Ronen Zvulun)
Advertisement
var articleID = window.location.pathname.substring( window.location.pathname.lastIndexOf("-")+1);
var articlesWithoutLinkPremium = ["661248", "661185", "661893", "665206", "602479"];
if( articlesWithoutLinkPremium.includes(articleID) == true)
{
document.getElementById("premium-link").style.display = "none";
}
var cont = `Sign up for The Jerusalem Post Premium Plus for just $5 Upgrade your reading experience with an ad-free environment and exclusive content